Core A Publication

Recent papers (2010 Apr - 2015 Mar Project Period)

1.	Abdu, E., D.A. Bruun, D.R. Yang, J. Yang, B. Inceoglu, B.D. Hammock, N.J. Alkayed and P.J. Lein. 2011. Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures. J Neurochem. 117(4):632-42. PMCID: PMC3081369.
2.	Baumann, A., W. Lohmann, T. Rose, K.C. Ahn, B.D. Hammock, U. Karst and N.H. Schebb. 2010. Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolites. Drug Metab Dispos. 38(12):2130-38. PMCID: PMC2993458. (Arra - UCSD; 3P42ES004699-23S3)
3.	Charles, R.L., J.R. Burgoyne, M. Mayr, S.M. Weldon, N. Hubner, H. Dong, C. Morisseau, B.D. Hammock, A. Landar and P. Eaton. 2011. Redox regulation of soluble epoxide hydrolase by 15-Deoxy-?-Prostaglandin J2 controls coronary hypoxic vasodilation. Circ Res. 108(3):324-34. PMCID: PMC3259859. (Project 5)
4.	Cherednichenko G, Z hang R, Bannister RA, Timofeyev V, Li N, Fritsch EB, Feng W, Barrientos GC, Schebb NH, Hammock BD, Beam KG, Chiamvimonvat N, Pessah IN. Triclosan impairs excitation-contraction coupling and Ca2+ dynamics in striated muscle. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14158-63. PMCID: PMC3435154. (Project 5)
5.	Davis, B.B., J.Y. Liu, D.J. Tancredi, L. Wang, S.I. Simon, B.D. Hammock and K.E. Pinkerton. 2011. The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment. Biochem Biophys Res Commun. 410(3):494-500. PMCID: PMC3166856.
6.	Eiserich JP, Yang J, Morrissey BM, Hammock BD, Cross CE. Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions. Ann N Y Acad Sci. 2012 Jul; 1259:1-9. PMCID: PMC3403728.
7.	Falck D, Schebb NH, Prihatiningtyas S, Z hang JW, Heus F, Morisseau C, Kool J, Hammock BD, Niessen WM. Development of on-line liquid chromatography-biochemical detection for soluble epoxide hydrolase inhibitors in mixtures. Chromatographia. 2013; 76(1-2):13-21. PMCID Journal: PMCID In process. (Project 5)
8.	Hwang, S.H., K.M. Wagner, C. Morisseau, J.Y. Liu, H. Dong, A.T. Wecksler and B.D. Hammock. 2011. Synthesis and structure – activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase. J Med Chem. 54(8):3037-50. PMCID: PMC3281519. (Project 5)
9.	Koeners, M.P., S. Wesseling, A. Ulu, R.L. Sepúlveda, C. Morisseau, B. Braam, B.D. Hammock and J.A. Joles. 2011. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am J Physiol Endocrinol Metab. 300(4)E691-98. PMCID: PMC3074945. (Project 5)
10.	Kubala, L., K.R. Schmelzer, A. Klinke, H. Kolarova, S. Baldus, B.D. Hammock and J.P. Eiserich. 2010. Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation. Free Radica Biol Med. 48(10):1311-20. PMCID: PMC2856720.
11.	ceoglu AB, Clifton HL, Yang J, Hegedus C, Hammock BD, Schaefer S. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice. J Cardiovasc Pharmacol. 2012 Jul; 60(1):70-5. PMCID: PMC3396292. (Project 5)
12.	Inceoglu B, Wagner KM, Yang J, Bettaieb A, Schebb NH, Hwang SH, Morisseau C, Haj FG, Hammock BD. Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes. Proc Natl Acad Sci U S A. 2012 Jul 10; 109(28):11390-5. PMCID: PMC3396532.
13.	Kim IH, Nishi K, Kasagami T, Morisseau C, Liu JY, Tsai HJ, Hammock BD. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase. Bioorg Med Chem Lett. 2012 Sep 15; 22(18):5889-92. PMCID: PMC3432147. (Project 5)
14.	Li, N., J.Y. Liu, H. Qiu, T. Harris, P. Sirish, B.D. Hammock and N. Chiamvimonvat. 2011. Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease. Congest Heart Fail. 17(1):42-46. PMID: 21272227.
15.	Lin Y, Ubels JL, Schotanus MP, Yin Z , Pintea V, Hammock BD, Watsky MA. Enhancement of vitamin D metabolites in the eye following vitamin D3 supplementation and UV-B irradiation. Curr Eye Res. 2012 Oct; 37(10):871-8. NIHMSID: 417313. PMCID Journal: PMCID In process.
16.	Liu, J.Y., H. Qiu, C. Morisseau, S.H. Hwang, H.J. Tsai, A. Ulu, N. Chiamvimonvat and B.D. Hammock. 2011. Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model. Toxicol Appl Pharmacol. 255(2)200-06. PMCID: PMC3156297. (Project 5) (Arra - ASU)
17.	Lundström SL, Yang J, Källberg HJ, Thunberg S, Gafvelin G, Haeggström JZ , Grönneberg R, Grunewald J, van Hage M, Hammock BD, Eklund A, Wheelock ÅM, Wheelock CE. Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. PLoS One. 2012; 7(3):e33780. PMCID: PMC3305349.
18.	Morisseau C, Schebb NH, Dong H, Ulu A, Aronov PA, Hammock BD. Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids. Biochem Biophys Res Commun. 2012 Mar 23; 419(4):796-800. PMCID: PMC3313618. (Project 5)
19.	Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, Barnés CM, Mammoto A, Mammoto T, Luria A, Benny O, Chaponis DM, Dudley AC, Greene ER, Vergilio JA, Pietramaggiori G, Scherer-Pietramaggiori SS, Short SM, Seth M, Lih FB, Tomer KB, Yang J, Schwendener RA, Hammock BD, Falck JR, Manthati VL, Ingber DE, Kaipainen A, D'Amore PA, Kieran MW, Z eldin DC. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest. 2012 Jan 3; 122(1):178-91. PMCID: PMC3248288.
20.	Qiu H, Liu JY, Wei D, Li N, Yamoah EN, Hammock BD, Chiamvimonvat N. Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischaemia. Cardiovasc Res. 2012 Aug 1; 95(3):336-45. PMCID: PMC3400359.
21.	Schebb, N.H., B. Inceoglu, K.C. Ahn, C. Morisseau, S.J. Gee and B.D. Hammock. 2011. Investigation of human exposure to triclocarban after showering and preliminary evaluation of its biological effects. Environ Sci Technol. 45(7):3109-15. (Project 3 & 5) (Arra - UCSD & Arra - ASU)
22.	Schebb, N.H., M. Huby, C. Morisseau, S.H. Hwang and B.D. Hammock. 2011. Development of an online SPE-LC-MS-based assay using endogenous substrate for the investigation of soluble epoxide hydrolase (sEH) inhibitors. Anal Bioanal Chem. 400(5):1359-66. PMCID: PMC3081056. (Project 5)
23.	Schebb, N.H., B. Inceoglu, T. Rose, K. Wagner and B.D. Hammock. 2011. Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies. Anal Methods. 3(2):420-28. PMCID: PMC3110015.
24.	Schebb NH, Franze B, Maul R, Ranganathan A, Hammock BD. In vitro glucuronidation of the antibacterial triclocarban and its oxidative metabolites. Drug Metab Dispos. 2012 Jan; 40(1):25-31. PMCID: PMC3250046. (Project 3)
25.	Schebb NH, Ahn KC, Dong H, Gee SJ, Hammock BD. Whole blood is the sample matrix of choice for monitoring systemic triclocarban levels. Chemosphere. 2012 May; 87(7):825-7. PMCID: PMC3538789. (Project 3)
26.	Stephensen CB, Z erofsky M, Burnett DJ, Lin YP, Hammock BD, Hall LM, McHugh T. Ergocalciferol from mushrooms or supplements consumed with a standard meal increases 25-hydroxyergocalciferol but decreases 25-hydroxycholecalciferol in the serum of healthy adults. J Nutr. 2012 Jul; 142(7):1246-52. PMCID Journal: PMCID In process.
27.	Ulu A, Appt S, Morisseau C, Hwang SH, Jones PD, Rose TE, Dong H, Lango J, Yang J, Tsai HJ, Miyabe C, Fortenbach C, Adams MR, Hammock BD. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys. Br J Pharmacol. 2012 Mar; 165(5):1401-12. PMCID: PMC3372725. (Project 5)
28.	Wang L, Yang J, Guo L, Uyeminami D, Dong H, Hammock BD, Pinkerton KE. Use of a soluble epoxide hydrolase inhibitor in smoke- induced chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2012 May; 46(5):614-22. PMCID: PMC3359909.
29.	Yang, J., H. Dong and B.D. Hammock. 2011. Profiling the regulatory lipids: another systemic way to unveil the biological mystery. Curr Opin Lipidol. 22(3): 197-203. PMCID: PMC In Process.
30.	Yin, Z., V. Pintea, Y.P. Lin, B.D. Hammock and M.A. Watsky MA. 2011. Vitamin D Enhances Corneal Epithelial Barrier Function. Invest Ophthalmol Vis Sci. 52(10): 7359-64. PMCID: PMC3183972
31.	Yang J, Eiserich JP, Cross CE, Morrissey BM, Hammock BD. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med. 2012 Jul 1; 53(1):160-71. PMCID: PMC3412514.
32.	Yueh MF, Li T, Evans RM, Hammock B, Tukey RH. Triclocarban mediates induction of xenobiotic metabolism through activation of the constitutive androstane receptor and the estrogen receptor alpha. PLoS One. 2012; 7(6):e37705. PMCID: PMC3376094. (Project 5)
33.	Zhang W, Yang AL, Liao J, Li H, Dong H, Chung YT, Bai H, Matkowskyj KA, Hammock BD, Yang GY. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice. Dig Dis Sci. 2012 Oct; 57(10):2580-91. NIHMSID: 438334.
34.	Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O'Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C, Hammock BD. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics. 2012; 8(6):1102-13. NIHMSID: 438336. PMCID Journal: PMCID In process.

*Collaborative publications in bold

Core A archive from 2005 Apr -2010 Mar Project Period